| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,740,804 | 1,733,505 | 1,835,631 | 1,867,587 | | Cost of Revenue | 838,101 | 804,298 | 891,545 | 917,362 | | | Gross Profit | 902,703 | 929,207 | 944,086 | 950,225 | | | Operating Expenses | | Research Development | 98,734 | 97,457 | 108,605 | 100,072 | | Selling General and Administrative | 440,502 | 409,942 | 437,217 | 440,588 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 363,467 | 421,808 | 398,264 | 409,565 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,389) | 11,062 | 5,143 | 9,672 | | Earnings Before Interest And Taxes | 362,078 | 432,870 | 403,407 | 419,237 | | Interest Expense | 7,495 | 7,824 | 8,888 | 9,017 | | Income Before Tax | 354,583 | 425,046 | 394,519 | 410,220 | | Income Tax Expense | 93,255 | 112,978 | 110,542 | 112,810 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 261,328 | 312,068 | 283,977 | 297,410 | | | Non-recurring Events | | Discontinued Operations | (54) | 14 | (1,802) | (321) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 261,274 | 312,082 | 282,175 | 297,089 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $261,274 | $312,082 | $282,175 | $297,089 |
|
0.45% Nasdaq 
0.20%
Income Statement
